insights_auto
Why is PEB up 15.79%?
Dive Deeperchevron_right
PEB:ASX
Pacific Edge Ltd
A$0.22
arrow_upward
+15.79%(+0.030) 1D
Nov 6, 4:10:28 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEB...
Open
A$0.22
High
A$0.24
Low
A$0.22
Mkt. cap
312.03M
Avg. vol.
11.77K
Volume
1.08M
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
Open
A$0.22
High
A$0.24
Low
A$0.22
Mkt. cap
312.03M
Avg. vol.
11.77K
Volume
1.08M
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
News stories
From web sources and news partners
RNZ
·
2 days ago
Shares in cancer diagnostics company Pacific Edge rise after Medicare coverage of tests
Stocks Down Under
·
2 days ago
Pacific Edge (ASX:PEB) Medicare Just Picked Its Tests. Can Revenue Finally Follow?
BusinessDesk
·
2 days ago
Pacific Edge shares lift 16% after it gains Cxbladder Medicare coverage
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd
CEO-
Employees114
Founded2001
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitepacificedgedx.com